Instituto Rosenbusch Statistics

Total Valuation

BCBA:ROSE has a market cap or net worth of ARS 3.58 billion. The enterprise value is 4.63 billion.

Market Cap	3.58B
Enterprise Value	4.63B

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025.

Earnings Date	May 21, 2025
Ex-Dividend Date	n/a

Share Statistics

BCBA:ROSE has 42.59 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	42.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	80.05%
Owned by Institutions (%)	n/a
Float	8.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
PB Ratio	1.18
P/TBV Ratio	1.26
P/FCF Ratio	6.66
P/OCF Ratio	6.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.28, with an EV/FCF ratio of 8.62.

EV / Earnings	-3.27
EV / Sales	0.56
EV / EBITDA	2.28
EV / EBIT	2.48
EV / FCF	8.62

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.57.

Current Ratio	1.79
Quick Ratio	0.83
Debt / Equity	0.57
Debt / EBITDA	0.86
Debt / FCF	3.24
Interest Coverage	2.99

Financial Efficiency

Return on equity (ROE) is -42.35% and return on invested capital (ROIC) is 20.21%.

Return on Equity (ROE)	-42.35%
Return on Assets (ROA)	12.62%
Return on Invested Capital (ROIC)	20.21%
Return on Capital Employed (ROCE)	44.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.89
Inventory Turnover	1.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.65% in the last 52 weeks. The beta is 0.02, so BCBA:ROSE's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-17.65%
50-Day Moving Average	105.07
200-Day Moving Average	104.50
Relative Strength Index (RSI)	27.48
Average Volume (20 Days)	7,328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCBA:ROSE had revenue of ARS 8.27 billion and -1.42 billion in losses. Loss per share was -33.28.

Revenue	8.27B
Gross Profit	3.79B
Operating Income	1.87B
Pretax Income	-1.42B
Net Income	-1.42B
EBITDA	2.03B
EBIT	1.87B
Loss Per Share	-33.28

Full Income Statement

Balance Sheet

The company has 877.12 million in cash and 1.74 billion in debt, giving a net cash position of -863.17 million or -20.27 per share.

Cash & Cash Equivalents	877.12M
Total Debt	1.74B
Net Cash	-863.17M
Net Cash Per Share	-20.27
Equity (Book Value)	3.03B
Book Value Per Share	66.74
Working Capital	2.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 547.56 million and capital expenditures -10.37 million, giving a free cash flow of 537.19 million.

Operating Cash Flow	547.56M
Capital Expenditures	-10.37M
Free Cash Flow	537.19M
FCF Per Share	12.61

Full Cash Flow Statement

Margins

Gross margin is 45.75%, with operating and profit margins of 22.61% and -17.13%.

Gross Margin	45.75%
Operating Margin	22.61%
Pretax Margin	-17.15%
Profit Margin	-17.13%
EBITDA Margin	24.55%
EBIT Margin	22.61%
FCF Margin	6.49%

Dividends & Yields

BCBA:ROSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-39.62%
FCF Yield	15.02%

Stock Splits

The last stock split was on November 16, 2011. It was a forward split with a ratio of 1.43614361.

Last Split Date	Nov 16, 2011
Split Type	Forward
Split Ratio	1.43614361

Scores

BCBA:ROSE has an Altman Z-Score of 2.3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.3
Piotroski F-Score	n/a